“…The most recent meta-analysis [38] involved 3,966 patients from 38 trials, and reported a significant 50% reduction in mortality (1.3% vs. 2.6%) in the volatile anesthetic group versus the propofol group. Other metaanalyses have reported 47% reductions in myocardial infarction, 69% reductions in postoperative inotrope use [37], and 36.6% reductions in cardiac enzyme release [39].…”